Latest Capital Management News

Sonic Healthcare has delivered solid FY 2025 results, meeting EBITDA guidance with 5% organic revenue growth and setting the stage for up to 19% EPS growth in FY 2026, driven by strategic acquisitions and operational synergies.

NAOS Ex-50 Opportunities Company Limited reported a strong FY25 with a 28.92% portfolio return and maintained its annual dividend at 6.0 cents per share, reflecting robust capital management and investor confidence.

Codan Limited reported a robust FY25 with revenue climbing 22% to $674.2 million and net profit rising 27%, driven by strong performances in its Communications and Metal Detection segments.

Codan Limited has delivered a robust FY25 performance, with revenue up 22% and net profit rising 27%, underpinned by strong growth in its Communications and Metal Detection segments. The company also announced a 27% increase in dividends and a significant reduction in net debt.

Eureka Group Holdings Limited reported robust FY25 financial results, driven by strong rental demand and strategic acquisitions across Queensland and New South Wales. The company signals continued growth with a significant development pipeline and optimistic FY26 guidance.

Downer EDI Limited has announced an on-market buy-back of up to 33.6 million ordinary shares, set to run from September 2025 through June 2026. The move signals a strategic capital management initiative without requiring shareholder approval.

Eureka Group Holdings reports robust FY25 results with double-digit revenue and profit growth, boosted by strong rental demand and strategic acquisitions. The company signals continued expansion and operational efficiency improvements ahead.

Universal Store Holdings reported a robust FY25 with 15.5% revenue growth to $333.3 million, driven by strong like-for-like sales and new store openings. Despite a goodwill impairment in its CTC segment, the group declared a solid final dividend and advanced its sustainability agenda.

Eureka Group Holdings Limited has reported a robust financial year ending June 2025, with net profit soaring 51.9% and a strategic portfolio expansion in seniors and affordable rental accommodation.

Downer EDI Limited reported a robust FY25 with a 33% rise in underlying NPATA and announced a $230 million share buy-back, underscoring confidence in its transformation and growth outlook. The company’s disciplined portfolio simplification and operational improvements set the stage for steady FY26 performance despite short-term market softness.

Medical Developments International has reported a remarkable turnaround in FY25, posting a net profit after tax and securing paediatric approval for its flagship product Penthrox in Europe.

Medical Developments International reports a strong FY25 with significant margin gains and strategic progress, setting the stage for accelerated Penthrox expansion in FY26.